Trexquant Investment LP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,527,120
+23.8%
43,526
+14.8%
0.06%
+16.7%
Q2 2023$2,041,180
+526.2%
37,919
+362.1%
0.05%
+500.0%
Q1 2023$325,942
-30.7%
8,206
-19.5%
0.01%
-69.0%
Q4 2021$470,000
+129.3%
10,199
+44.5%
0.03%
+31.8%
Q4 2020$205,000
-21.2%
7,059
+67.6%
0.02%
+46.7%
Q4 2019$260,000
+26.8%
4,213
+19.5%
0.02%
+7.1%
Q1 2018$205,000
-91.3%
3,526
-94.1%
0.01%
-93.1%
Q3 2015$2,344,000
+263.4%
59,346
+470.6%
0.20%
+180.6%
Q2 2015$645,000
+17.3%
10,400
+18.2%
0.07%
+28.6%
Q1 2015$550,0008,8000.06%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders